Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke

NCT01098981 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

675

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DEVICE: Transcranial ultrasound as an adjunctive therapy to tPA
DRUG: Standard of care tPA therapy for acute ischemic stroke

Sponsor

Cerevast Therapeutics, Inc.